
FOLD
Amicus Therapeutics Inc.
$8.57
+$0.24(+2.88%)
70
Overall
--
Value
70
Tech
--
Quality
Market Cap
$2.57B
Volume
4.28M
52W Range
$5.51 - $12.65
Target Price
$15.92
EPS Estimates Overview
Current Quarter | $0.05 | Next Quarter | $0.08 |
Current Year | $0.03 | Next Year | $0.4 |
QoQ Growth | +60.0% | YoY Growth | +1233.3% |
3Y EPS CAGR | +41.9% | Target Price | $15.92 |
Consensus | Buy | Upside | +85.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
Current Quarter Rev | N/A | Next Quarter Rev | N/A |
Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | FOLD | $8.57 | +2.9% | 4.28M |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Amicus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW